Upregulation of CD40/CD40L system in rheumatic mitral stenosis with or without atrial fibrillation

Author： Azzam Hanan Abousamra Nashwa K. Wafa Ahmad A. Hafez Mona M. El-Gilany Abdel-Hady

ISSN： 1369-1635

Source： Platelets, Vol.24, Iss.7, 2013-11, pp. : 516-520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD40-CD40L Interactions in Atherosclerosis

By Lutgens E. Daemen M.J.A.P.

Trends in Cardiovascular Medicine, Vol. 12, Iss. 1, 2002-01 ,pp. : 27-32

Elsevier

Access to resources Recommend Favorite

Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel

By Hermann Alexander Rauch Bernhard H. Braun Marina Schrör Karsten Weber Artur-Aron

Platelets, Vol. 12, Iss. 2, 2001-03 ,pp. : 74-82

Informa Healthcare

Access to resources Recommend Favorite

Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets

By Reinboldt Stephan Wenzel Folker Rauch Bernhard Hohlfeld Thomas Grandoch Maria Fischer Jens Weber Artur-Aron

Platelets, Vol. 20, Iss. 6, 2009-09 ,pp. : 441-444

Informa Healthcare

Access to resources Recommend Favorite

Prediction of atrial fibrillation in patients with severe mitral stenosis--role of atrial contribution to ventricular filling

By Krishnamoorthy K. M. Dash P. K.

Scandinavian Cardiovascular Journal, Vol. 37, Iss. 6, 2003-11 ,pp. : 344-348

Informa Healthcare

Access to resources Recommend Favorite

Soluble CD40 Ligand Levels in Patients with Hypertension

By Sonmez Alper Dogru T. Yilmaz M. Ocal R. Ozgurtas T. Kilic S. Eyileten T. Tasci I. Erbil K. Kocar I.

Clinical and Experimental Hypertension, Vol. 27, Iss. 8, 2005-11 ,pp. : 629-634

Informa Healthcare

Access to resources Recommend Favorite